Title

Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease.

Creator(s)

Kyle Gress
Julie A. Bass, Children's Mercy HospitalFollow
Ryan S Funk
Ryan Morrow, Children's Mercy HospitalFollow
Rachel Hasenkamp, Children's Mercy HospitalFollow
Valentina Shakhnovich, Children's Mercy HospitalFollow

Document Type

Article

Publication Date

6-9-2020

Identifier

DOI: 10.3389/fimmu.2020.01148; PMCID: PMC7295975

Journal Title

Front Immunol

Volume

11

Keywords

TNF-α; adalimumab; anti-drug antibodies; biologics; children; immunogenicity; inflammatory bowel disease; infliximab

Comments

Grant support

• KL2 TR002367/TR/NCATS NIH HHS/United States
• L40 TR000598/TR/NCATS NIH HHS/United States
• P20 GM130423/GM/NIGMS NIH HHS/United States

Recommended Citation

Gress, K., Bass, J. A., Funk, R., Morrow, R., Hasenkamp, R., Shakhnovich, V. Facing Real-World Challenges of Immunogenicity in Pediatric Inflammatory Bowel Disease. Front Immunol 11, (2020).